Created at	Source	Raw Value	Validated value
July 31, 2021, 4:30 p.m.	eu	-Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program (cohort I) -Having received SARS-CoV-2 vaccination with Pfizer or Moderna as part of the national vaccination program with the last vaccination less than 4 weeks before study entry (cohort II) -Written informed consent	-Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program (cohort I) -Having received SARS-CoV-2 vaccination with Pfizer or Moderna as part of the national vaccination program with the last vaccination less than 4 weeks before study entry (cohort II) -Written informed consent
June 22, 2021, 2:30 a.m.	eu	-Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program -Written informed consent	-Willing to receive routine COVID-19 vaccination with Pfizer or Moderna vaccine as part of the national vaccination program -Written informed consent